Appendix H
Membership of Oversight Boards and Committees
COMMITTEE ON SCIENCE, TECHNOLOGY, AND LAW
DONALD KENNEDY (NAS/IOM), (Co-Chair), President Emeritus and Bing Professor of Environmental Science Emeritus, Stanford University; Emeritus Editor-in-Chief, Science
RICHARD A. MERRILL (IOM), (Co-Chair), Daniel Caplin Professor of Law Emeritus, University of Virginia Law School
FREDERICK R. ANDERSON, JR., Partner, McKenna, Long & Aldridge LLP
ARTHUR I. BIENENSTOCK, Special Assistant to the President for SLAC and Federal Research Policy, Stanford University
BARBARA E. BIERER, Senior Vice President for Research, Brigham and Women’s Hospital
ELIZABETH H. BLACKBURN (NAS/IOM), Morris Herzstein Professor of Biology and Physiology, Department of Biochemistry and Biophysics, University of California, San Francisco
JOE S. CECIL, Project Director, Program on Scientific and Technical Evidence, Federal Judicial Center
RICHARD F. CELESTE, President, Colorado College
JOEL E. COHEN (NAS), Abby Rockefeller Mauzé Professor and Head, Laboratory of Populations, The Rockefeller University and Columbia University
ROCHELLE COOPER DREYFUSS, Pauline Newman Professor of Law and Director, Engelberg Center on Innovation Law and Policy, New York University School of Law
ALICE P. GAST (NAE), President, Lehigh University
LAWRENCE O. GOSTIN (IOM), Associate Dean for Research and Academic Programs, Linda D. and Timothy J. O’Neill Professor
of Global Health Law, and Faculty Director, O’Neill Institute for National and Global Health Law, Georgetown University; Professor of Public Health, The Johns Hopkins University; Director of the Center for Law & the Public’s Health, The Johns Hopkins and Georgetown Universities
GARY W. HART, Wirth Chair Professor, School of Public Affairs, University of Colorado, Denver
BENJAMIN W. HEINEMAN, JR., Senior Fellow, Harvard Law School and Harvard Kennedy School of Government
DAVID BROCK HORNBY, Judge, U.S. District Court, District of Maine
DAVID KORN (IOM), Chief Scientific Officer, Association of American Medical Colleges
RICHARD A. MESERVE (NAE), President, Carnegie Institution for Science and Senior Of Counsel, Covington & Burling, LLP
DUNCAN T. MOORE (NAE), Professor, The Institute of Optics, University of Rochester
ALAN B. MORRISON, Attorney, Fail Elections Legal Network
HARRIET RABB, Vice President and General Counsel, Rockefeller University
PAUL D. RHEINGOLD, Senior Partner, Rheingold, Valet, Rheingold, Shkolnik & McCartney LLP
BARBARA ROTHSTEIN, Director, Federal Judicial Center
JONATHAN M. SAMET (IOM), Professor and Chairman, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health
DAVID S. TATEL, Judge, U.S. Court of Appeals for the District of Columbia
Staff
ANNE-MARIE MAZZA, Director
GURUPRASAD MADHAVAN, Program Officer (until November 2010)
STEVEN KENDALL, Senior Program Associate
BOARD ON LIFE SCIENCES
KEITH R. YAMAMOTO (NAS/IOM), (Chair), Professor of Cellular and Molecular Pharmacology and Executive Vice Dean, School of Medicine, University of California, San Francisco
ANN M. ARVIN (IOM), Lucile Packard Professor in Pediatrics and Microbiology & Immunology and Vice Provost and Dean of Research, Stanford University School of Medicine
BONNIE L. BASSLER (NAS), Howard Hughes Medical Institute Investigator and Squibb Professor of Molecular Biology, Princeton University
VICKI L. CHANDLER (NAS), Chief Program Officer for Science, Gordon and Betty Moore Foundation and Regents’ Professor, Departments of Plant Sciences and Molecular & Cellular Biology, University of Arizona
SEAN EDDY, Group Leader, Janelia Farm Research Campus, Howard Hughes Medical Institute
MARK D. FITZSIMMONS, Associate Director, MacArthur Fellows Program, John D. and Catherine T. MacArthur Foundation
DAVID R. FRANZ, Vice President and Chief Biological Scientist, Midwest Research Institute and Senior Advisor, Office of the Assistant to the Secretary of Defense for Nuclear, Chemical and Biological Defense Programs
LOUIS J. GROSS, James R. Cox Professor in Ecology and Evolutionary Biology and Mathematics and Director, The Institute for Environmental Modeling, University of Tennessee; and Director, National Institute for Mathematical and Biological Synthesis
JO HANDELSMAN, Howard Hughes Medical Institute Professor and Chair, Department of Bacteriology, University of Wisconsin–Madison
CATO T. LAURENCIN (IOM), Van Dusen Endowed Chair in Academic Medicine, Distinguished Professor of Orthopaedic Surgery, and Vice President for Health Affairs, University of Connecticut Health Center; and Dean, University of Connecticut School of Medicine, University of Connecticut Health Center
JONATHAN D. MORENO (IOM), David and Lyn Silfen University Professor of Ethics and Professor of Medical Ethics and of History and Sociology of Science, University of Pennsylvania; and Senior Fellow, Center for American Progress
ROBERT M. NEREM (NAE/IOM), Robert H. Petit Distinguished Chair for Engineering in Medicine and Institute Professor and Director, Parker H. Petit Institute for Bioengineering and Bioscience; and Director, Georgia Tech/Emory Center for the Engineering of Living Tissue, Georgia Institute of Technology
CAMILLE PARMESAN, Associate Professor of Integrative Biology, University of Texas at Austin
MURIEL E. POSTON, Dean of the Faculty and Professor of Biology, Skidmore College
ALISON G. POWER, Dean of the Graduate School and Professor of Ecology and Evolutionary Biology and of Science & Technology Studies, Cornell University
BRUCE W. STILLMAN (NAS), President and Chief Executive Officer, Cold Spring Harbor Laboratory
CYNTHIA WOLBERGER, Howard Hughes Medical Institute Investigator and Professor of Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine
MARY WOOLLEY (IOM), President and Chief Executive Officer, Research!America
Staff
FRANCES E. SHARPLES, Director
JO L. HUSBANDS, Scholar/Senior Project Director
ADAM P. FAGEN, Senior Program Officer
ANN H. REID, Senior Program Officer
MARILEE K. SHELTON-DAVENPORT, Senior Program Officer
INDIA HOOK-BARNARD, Program Officer
ANNA FARRAR, Financial Associate
AMANDA P. CLINE, Senior Program Assistant (until May 2010)
REBECCA L. WALTER, Senior Program Assistant
CARL-GUSTAV ANDERSON, Program Assistant
FORUM ON DRUG DISCOVERY, DEVELOPMENT, AND TRANSLATION
GAIL CASSELL (IOM), (Co-Chair), Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases, Eli Lilly and Company
JEFFREY DRAZEN (IOM), (Co-Chair), Editor-in-Chief, New England Journal of Medicine
BARBARA ALVING, Director, National Center for Research Resources, National Institutes of Health
LESLIE BENET (IOM), Professor, Department of Biopharmaceutical Sciences, School of Pharmacy, University of California, San Francisco
ANN BONHAM, Chief Scientific Officer, Association of American Medical Colleges
CATHERINE BONUCCELLI, Vice President, Development Projects, Symbicort, AstraZeneca Pharmaceuticals
LINDA BRADY, Director, Division of Neuroscience and Basic Behavioral Science, National Institute of Mental Health
ROBERT CALIFF, Director, Duke Translational Medicine Institute, Professor of Medicine and Vice Chancellor for Clinical and Translational Research, Duke University Medical Center
SCOTT CAMPBELL, National Vice President, American Diabetes Association
C. THOMAS CASKEY (NAS/IOM), Chief Operating Officer and Director/CEO, University of Texas HSC at Houston
PETER CORR, Co-Founder and General Partner, Celtic Therapeutics LLLP
JAMES DOROSHOW, Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute
PAUL EISENBERG, Senior Vice President, Global Regulatory Affairs and Safety, Amgen Inc.
GARY FILERMAN, Senior Vice President and Chairman, Health Management and Policy Group, ATLAS Research
GARRET FITZGERALD (IOM), Professor of Medicine, Professor and Chair of Pharmacology, Department of Pharmacology, University of Pennsylvania School of Medicine
ELAINE GALLIN, Director, Medical Research Programs, Doris Duke Charitable Foundation
STEVEN GALSON, Senior Vice President, Science Operations International Corporation
MIKHAIL GISHIZKY, Chief Scientific Officer, Entelos, Inc.
HARRY GREENBERG, Senior Associate Dean for Research, Joseph D. Grant Professor of Medicine and Microbiology & Immunology, Stanford University School of Medicine
STEPHEN GROFT, Director, Office of Rare Disease Research, National Institutes of Health
PETER HONIG, Former Executive Vice President for Worldwide Regulatory Affairs and Product Safety within Development, Merck Research Laboratories
ANNALISA JENKINS, Senior Vice President Global Medical, Bristol Myers Squibb
MICHAEL KATZ (IOM), Senior Vice President for Research and Global Programs, March of Dimes Foundation
JACK KEENE, James B. Duke Professor, Molecular Genetics & Microbiology, Duke University Medical Center
RONALD KRALL, Senior Vice President and Chief Medical Officer, GlaxoSmithKline
FREDA LEWIS-HALL, Chief Medical Officer, SVP, Pfizer
WILLIAM MATTHEW, Director of Translational Research, NINDS National Institutes of Health
MARK MCCLELLAN (IOM), Director, Engelberg Center for Health Care Reform, The Brookings Institution
CAROL MIMURA, Assistant Vice Chancellor for Intellectual Property & Industry Research Alliances (IPIRA), University of California, Berkeley
JOHN ORLOFF, Senior Vice President, US Medical & Drug Regulatory Affairs, Novartis Pharmaceuticals Corporation
AMY PATTERSON, Acting Director, Office of Science Policy, National Institutes of Health
JANET SHOEMAKER, Director, Office of Public Affairs, American Society for Microbiology
LANA SKIRBOLL, Acting Director, Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health
NANCY SUNG, Senior Program Officer, Burroughs-Wellcome Fund
JORGE TAVEL, Deputy Director, Division of Clinical Research, National Institute of Allergy and Infectious Diseases
JANET TOBIAS, President Sierra/Tango Productions, Ikana Media
JOANNE WALDSTREICHER, Head of Global Development, CNS/IM Franchise
JANET WOODCOCK, Deputy Commissioner and Chief Medical Officer, U.S. Food and Drug Administration
RAYMOND WOOSLEY, President and CEO, The Critical Path Institute
Staff
ROBERT GIFFIN, Forum Director (until February 2010)
SALLY CLUCHEY, Program Officer (until October 2009)
ROUNDTABLE ON TRANSLATING GENOMIC-BASED RESEARCH FOR HEALTH
WYLIE BURKE, (IOM), (Chair), Professor and Chair, Department of Bioethics and Humanities, University of Washington
BRUCE BLUMBERG, Co-Chief of Medical Genetics, Kaiser-Permanente, Oakland, and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente
DENISE E. BONDS, Medicial Director, Division of Prevention & Population Sciences, National Heart, Lung, and Blood Institute
C. THOMAS CASKEY (NAS/IOM), Director and Chief Executive Officer, The George & Cynthia Mitchell Distinguished Chair in Neurosciences and Executive Vice President of Molecular Medicine and Genetics, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston
STEPHEN ECK, Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly and Company
ANDREW N. FREEDMAN, Genetic Epidemiologist, Risk Factor Monitoring and Methods Branch, Division of Cancer Control and Population Sciences, National Cancer Institute
GEOFFREY GINSBURG, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University
R. RODNEY HOWELL, Special Assistant to the Director, National Institute of Child Health and Human Development
KATHY HUDSON, Director, Genetics and Public Policy Center, Johns Hopkins Berman Institute of Bioethics (until July 2009)
SHARON KARDIA, Director, Public Health Genetic Programs Associate Professor, Department of Epidemiology, University of Michigan, School of Public Health
MOHAMED KHAN, Associate Director of Translational Research Department of Radiation Medicine, Roswell Park Cancer Institute
MUIN KHOURY, Director, National Office of Public Health Genomics, Centers for Disease Control and Prevention
ALLAN KORN, Chief Medical Officer, Senior Vice President Clinical Affairs, BlueCross/BlueShield Association
DEBRA LEONARD, Professor and Vice Chair of Laboratory Medicine Director of the Clinical Laboratories, Weill Cornell Medical Center
MICHELE LLOYD-PURYEAR, Chief, Genetic Services Branch, Health Resources and Services Administration
ELIZABETH MANSFIELD, Director of Personalized Medicine, Office of In Vitro Diagnostic Device Evaluation and Safety, Center for Devices and Radiological Health, U.S. Food and Drug Administration
GARRY NEIL, Corporate Vice President, Corporate Office of Science and Technology (COSAT), Johnson & Johnson
ROBERT L. NUSSBAUM (IOM), Chief, Division of Medical Genetics, Department of Medicine & Institute of Human Genetics, University of California, San Francisco, School of Medicine
KIMBERLY J. POPOVITS, President and CEO, Genomic Health, Inc.
AIDAN POWER, Vice President and Global Head of Molecular Medicine, Pfizer, Inc.
RONALD PRZYGODZKI, Associate Director for Genomic Medicine Biomedical Laboratory Research and Development, Department of Veterans Affairs
AMELIE G. RAMIREZ (IOM), Dielmann Chair, Health Disparities and Community Outreach Research and Director, Institute for Health Promotion Research, University of Texas Health Science Center at San Antonio
LAURA LYMAN RODRIGUEZ, Senior Advisor to the Director for Research Policy, National Human Genome Research Institute
ALLEN D. ROSES (IOM), Jefferson-Pilot Professor of Neurobiology and Genetics, Professor of Medicine, Director, Deane Drug Discovery Institute, and Senior Scholar, Fuqua School of Business R. David Thomas Executive Training Center, Duke University
KEVIN A. SCHULMAN, Professor of Medicine & Business Administration; Director, Center for Clinical and Genetic Economics; and Associate Director, Duke Clinical Research Institute, Duke University Medical Center
SHARON TERRY, President and CEO, Genetic Alliance
STEVEN TEUTSCH, Representative, Secretary’s Advisory Committee on Genetics, Health and Society
MARTHA TURNER, Assistant Director, Center for Ethics and Human Rights, American Nurses Association
MICHAEL S. WATSON, Executive Director, American College of Medical Genetics
CATHERINE A. WICKLUND, Director, Graduate Program in Genetic Counseling; Immediate Past President, National Society of Genetic Counselors; and Assistant Professor, Department of Obstetrics and Gynecology, Northwestern University
NATIONAL CANCER POLICY FORUM
HAROLD MOSES (IOM), (Chair), Director Emeritus, Vanderbilt-Ingram Cancer Center
FRED APPELBAUM, Director, Clinical Research Division, Fred Hutchinson Cancer Research Center
PETER BACH, Associate Attending Physician, Memorial Sloan-Kettering Cancer Center
EDWARD BENZ, JR., President, Dana Farber Cancer Institute
THOMAS BURISH, Past-Chair, American Cancer Society Board of Directors and Provost, Notre Dame University
MICHAELE CHAMBLEE CHRISTIAN, Former Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute
ROBERT ERWIN, President, Marti Nelson Cancer Foundation
BETTY FERRELL, Research Scientist, City of Hope National Medical Center
JOSEPH FRAUMENI, JR., Director, Division of Cancer Epidemiology and Genetics, National Cancer Institute
PATRICIA GANZ, Professor of Health Services, School of Public Health and Professor of Medicine, David Geffen School of Medicine, University of California, Los Angeles
ROBERT GERMAN, Associate Director for Science, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention
ROY HERBST, Chief, Thoracic/Head & Neck Medical Oncology, M.D. Anderson Cancer Center
THOMAS KEAN, Executive Director, C-Change
JOHN MENDELSOHN, President, M.D. Anderson Cancer Center
JOHN NIEDERHUBER, Director, National Cancer Institute
DAVID PARKINSON, President and CEO, Oncology Research and Development, Nodality Inc.
SCOTT RAMSEY, Member, Cancer Prevention Program, Division of Public Health Science, Fred Hutchinson Cancer Research Center
JOHN WAGNER, Executive Director, Clinical Pharmacology, Merck & Company, Inc.
JANET WOODCOCK, Deputy Commissioner and Chief Medical Officer, U.S. Food and Drug Administration
Staff
ROGER HERDMAN, Director (until September 2009)
ADAM SCHIKEDANZ, Staff (until June 2009)